Fenix Biotech
Madrid
About Fenix Biotech
Fenix Biotech is developing the nanocapsules based on a nano-encapsulation technological platform using chitosan. The project's aim is to carry out a quick and focused therapeutical test, which validates the technology of the DNA nano-encapsulation, to treat monogenetic diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $243.0K
- Last round: Series Unknown (Sep 2010)
- Website: genetrix.esenbiomedicine_companies_fenix_biotech.html
Industries & Categories
Biotechnology, Life Science, Medical
Canonical: https://fsome.com/organization/fenix-biotech-2738649 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.